Post-exposure HIV prophylaxis following sexual exposure: A retrospective audit against recent draft BASHH guidance

Sexually Transmitted Infections

Volumn 82, Issue 3, 2006, Pages 236-237

  Day, S ^a   Mears, A ^a   Bond, K ^a   Kulasegaram, R ^a,b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; ETHNOLOGY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; SEXUAL HEALTH; SEXUAL INTERCOURSE; TREATMENT DURATION;

ADULT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICAL AUDIT; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES; UNSAFE SEX;

EID: 33745133715     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2005.017764     Document Type: Article

References (3)

1. BASSH. United Kingdom guideline for the use of post-exposure prophylaxis for HIV following sexual exposure. www.bashh.org/guidelines/drart-04/ pepse%B1%5D_010404.doc.
2. Richens J, Edwards SG, Sadiq ST. Can the promotion of post-exposure prophylaxis following sexual exposure to HIV (PEPSE) cause harm? Response. Sex Transm Infect 2005;81:190-2.
3. Fisher M. Can the promotion of post-exposure prophylaxis following sexual exposure to HIV (PEPSE) cause harm? Response. Sex Transm Infect 2005;81:191-2.